Snapshot from Jul 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Roche launches cobas HDV test
Business product launch

Roche launches cobas HDV test

Analysis based on 7 articles · First reported Jul 14, 2026 · Last updated Jul 14, 2026

Sentiment
20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch strengthens Roche's diagnostics portfolio and may increase adoption of its cobas systems. It positions Roche to capture demand for HDV testing as new treatments enter the market, potentially boosting revenue in the infectious disease diagnostics segment.

diagnostics healthcare
Event Summary

Roche introduced the cobas HDV test, the first fully automated, high-throughput assay for detecting and quantifying Hepatitis D Virus (HDV) RNA, on its cobas 5800/6800/8800 systems. The test is available in countries accepting the CE mark. Hepatitis D affects about 12 million people globally and is the most severe form of viral hepatitis, often leading to liver failure and cancer. The new test addresses the need for consistent, widely accessible HDV testing, especially as new treatments become available. Roche Diagnostics CEO Matt Sause highlighted the test's role in improving outcomes for liver disease patients.

Key Actions
80 Roche introduced cobas HDV test
Entities Involved
stock
Roche
Roche introduced the cobas HDV test, expanding its diagnostics offering and reinforcing its leadership in automated molecular testing. The launch may drive incremental revenue and strengthen customer loyalty.
Importance 100.0 Sentiment 20.0
per
Matt Sause
As CEO of Roche Diagnostics, Matt Sause announced the product launch, underscoring Roche's commitment to liver disease diagnostics.
Importance 30.0 Sentiment 10.0
ngo
World Health Organization
The WHO is referenced as a source for Hepatitis D prevalence data; the test aligns with global health priorities for hepatitis elimination.
Importance 10.0 Sentiment 0.0
Relationships
Roche related ↔ Matt Sause
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.